Abstract Details
Mika Komori
PRESENTER |
Mika Komori has received personal compensation for serving as an employee of Eli Lilly K.K.. |
Andrew Blake (National Institutes of Health) | No disclosure on file |
No disclosure on file | |
Peter Kosa, PhD (NIH/NINDS) | Dr. Kosa has nothing to disclose. |
Danish Ghazali, MD | No disclosure on file |
No disclosure on file | |
Muktha Natrajan (National Institutes of Health) | No disclosure on file |
Simone C. Wuest, PhD (National Institutes of Health/NINDS) | No disclosure on file |
No disclosure on file | |
Anthony Traboulsee, MD (University of British Columbia) | Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers. |
Tianxia Wu | No disclosure on file |
Bibiana Bielekova, MD, FAAN (Neuroimmunological Diseases Section/NIAID/NIH) | Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care. |